scroll

Infomedia Ltd (IFM) – Broker Moves

Advanced Search

Our Q&As are emailed in our Saturday Morning Report, find the answer to this question below.

Ask a question

The Latest Q&A

Question asked 30/08/2025

Infomedia Ltd (IFM) – Broker Moves

Hi MM, I'm curious about the following broker move: • Infomedia Cut to Neutral at UBS; PT A$1.85 Do they realise that Infomedia have accepted a takeover offer at $1.72 or are they anticipating a competing offer/higher offer? Regards, Peter

Answer

Hi Peter,

UBS undoubtedly will know of the takeover, but their valuation will be determined by IFM’s FY25 results this week. Also note they may have downgraded the stock to neutral, but they also upgraded their PT by 5.7%.

Revenue came in at $146.5mn, up 4%, above expectations.
Net profit of $16.7mn was up 23%.
They are forecasting FY26 revenue of $152-159mn.

As you say TPG Capital Asia, acting through McQueen BidCo Pty Ltd. has bid for Infomedia. The transaction is structured under a scheme recommended by Infomedia’s board and awaits regulatory and shareholder approval.

UBS valuation will not take into account the bid, also don’t forget how many takeover attempts have fallen over at various hurdles in recent years.

chart

Infomedia Ltd (IFM)

LAST UPDATED 28/08/2025 11:58

Latest Reports

Weekend report 30/08/2025

Weekend Q&A: The volatile reporting season draws to a close – it’s been exhausting!

The ASX200 slipped 0.1% lower on Friday, but it still finished the week up +0.1%. As we’ve said a few times lately, it's feeling a touch tired above 9000. It was another week to remember from a reporting perspective, which dominated much of the movement on the sector level, although the materials sector continued to enjoy a strong recovery, topping the leader board for the week and month.

Afternoon report 29/08/2025

The Match Out: ASX dips as reporting season comes to a close

The ASX finished an up and down session slightly lower as reporting season volatility continued, with results headlined by strong gains in Harvey Norman and Mesoblast on the other side with ~10% moves for both continuing the trend of outsized share price reactions to earnings beats/misses.